AxoGen, Inc.
Status: Publicly traded
Direct answer
AxoGen, Inc. is publicly traded on NASDAQ under the ticker AXGN.
AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves. This avoids the need for a second surgical site for...
Can you invest in AxoGen, Inc.?
Yes. AxoGen, Inc. is publicly traded on NASDAQ under the ticker AXGN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for AxoGen, Inc.
Detailed equity research is provided by MarketSnap.